Association of 11q loss, trisomy 12, and possible 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor

Genes Chromosomes and Cancer

Volumn 45, Issue 6, 2006, Pages 592-601

  Watanabe, Naoki ^a,b   Nakadate, Hisaya ^c   Haruta, Masayuki ^a   Sugawara, Waka ^a   Sasaki, Fumiaki ^c   Tsunematsu, Yukiko ^c   Kikuta, Atsushi ^c   Fukuzawa, Masahiro ^c   Okita, Hajime ^c   Hata, Jun Ichi ^c   Soejima, Hidenobu ^d   Kaneko, Yasuhiko ^a,c  

^a SAITAMA CANCER CENTER   (Japan)

^b JUNTENDO UNIVERSITY NERIMA HOSPITAL   (Japan)

^c Japan Wilms Tumor Study Group   (Japan)

^d SAGA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B;

ARTICLE; CHILD; CHROMOSOME 11Q; CHROMOSOME 16Q; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; EVALUATION; FEMALE; GENE; GENE DELETION; GENE EXPRESSION; GENE INACTIVATION; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IGF2 GENE; INSULATOR ELEMENT; JAPAN; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; PRIORITY JOURNAL; TRISOMY 12; TUMOR SUPPRESSOR GENE;

CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 16; EPIGENESIS, GENETIC; GENOMIC IMPRINTING; HUMANS; INFANT; INSULIN-LIKE GROWTH FACTOR II; LOSS OF HETEROZYGOSITY; NUCLEIC ACID HYBRIDIZATION; TRISOMY; TUMOR CELLS, CULTURED; WILMS TUMOR; WT1 PROTEINS;

EID: 33646568520     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20321     Document Type: Article

References (30)

1. Beckwith JB, Palmer NF. 1978. Histopathology and prognosis of Wilms tumor: results from the First National Wilms' Tumor Study. Cancer 41:1937-1948.
2. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE. 1990. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509-520.
3. D'Angio GJ, Breslow N, Beckwith JB, Evans A, Baum H, deLorimier A, Fernbach D, Hrabovsky E, Jones B, Kelalis P, Othersen B, Tefft M, Thomas PRM. 1989. Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer 64:349-360.
4. Faussillon M, Monnier L, Junien C, Jeanpierre C. 2005. Frequent overexpression of cyclin D2/cyclin-dependent kinase 4 in Wilms' tumor. Cancer Lett 221:67-75.
5. Grundy PE, Telzerow PE, Breslow N, Moksness J, Huff V, Paterson MC. 1994. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome. Cancer Res 54:2331-2333.
6. Japanese Pathological Society. 1988. Committee on histological classification of childhood tumors: tumors of the urinary system. Kanahara Shuppan, Tokyo.
7. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE. 1991. Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Nat Acad Sci USA 88:9618-9622.
8. Hing S, Lu YJ, Summersgill B, King-Underwood L, Nicholson J, Grundy P, Grundy R, Gessler M, Shipley J, Pritchard-Jones K. 2001. Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors. Am J Pathol 158:393-398.
9. Huff V. 1998. Wilms tumor genetics. Am J Med Genet 79:260-267.
10. Koesters R, Ridder R, Kopp-Schneider A, Betts D, Adams V, Niggli F, Briner J. 1999. Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors. Cancer Res 59:3880-3882.
11. Kumon K, Kobayashi H, Namiki T, Tsunematsu Y, Miyauchi J, Kikuta A, Horikoshi Y, Komada Y, Hatae Y, Eguchi H, Kaneko Y. 2001. Frequent increase of DNA copy number in the 2q24 chromosomal region and its association with a poor clinical outcome in hepatoblastoma: cytogenetic and comparative genomic hybridization analysis. Jpn J Cancer Res 92:854-862.
12. Maiti S, Alam R, Amos CI, Huff V. 2000. Frequent association of beta-catenin and WT1 mutations in Wilms tumors. Cancer Res 60:6288-6292.
13. Mummert SK, Lobanenkov VA, Feinberg AP. 2005. Association of chromosome arm 16q loss with loss of imprinting of insulin-like growth factor-II in Wilms tumor. Genes Chromosomes Cancer 43:155-161.
14. Nakadate H, Tsuchiya T, Maseki N, Hatae Y, Tsunematsu Y, Horikoshi Y, Ishida Y, Kikuta A, Eguchi H, Endo M, Miyake M, Sakurai M, Kaneko Y. 1999. Correlation of chromosome abnormalities with presence or absence of WT1 deletions/mutations in Wilms tumor. Genes Chromosomes Cancer 25:26-32.
15. Nakadate H, Yokomori K, Watanabe N, Tsuchiya T, Namiki T, Kobayshi H, Suita S, Tsunematsu Y, Horikoshi Y, Hatae Y, Endo M, Komada Y, Eguchi H, Toyoda Y, Kikuta A, Kobayashi R, Kaneko Y. 2001. Mutations/deletions of the WT1 gene, loss of heterozygosity on chromosome arms 11p and 11q, chromosome ploidy and histology in Wilms' tumors in Japan. Int J Cancer 94:396-400.
16. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, Smith PJ, Reeve AE. 1993. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 62:749-751.
17. Ohlsson R, Renkawitz R, Lobanenkov V. 2001. CTCF is a uniquely-versatile transcription regulator linked to epigenetics and disease. Trends Genet 17:520-527.
18. Prawitt D, Enklaar T, Gartner-Rupprecht B, Spangenberg C, Oswald M, Lausch E, Schmidtke P, Reutzel D, Fees S, Lucito R, Korzon M, Brozek I, Limon J, Housman DE, Pelletier J, Zabel B. 2005. Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor. Proc Natl Acad Sci USA 102:4085-4090.
19. Radice P, Perotti D, De Benedetti V, Mondini P, Radice MT, Pilotti S, Luksch R, Fossati Bellani F, Pierotti MA. 1995. Allelotyping in Wilms tumors identifies a putative third tumor suppressor gene on chromosome 11. Genomics 27:497-501.
20. Rainier S, Dobry CJ, Feinberg AP. 1995. Loss of imprinting in hepatoblastoma. Cancer Res 55:1836-1838.
21. Rainier S, Johnson LA, Dobry CJ, Ping AJ. Grundy PE, Feinberg AP. 1993. Relaxation of imprint genes in human cancer. Nature 362:747-749.
22. Ravenel JD, Broman KW, Perlman EJ, Niemitz EL, Jayawardena TM, Bell DW, Haber DA, Uejima H, Feinberg AP. 2001. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor. J Natl Cancer Inst 93:1698-1703.
23. Ruteshouser EC, Hendrickson BW, Colella S, Krahe R, Pinto L, Huff V. 2005. Genome-wide loss of heterozygosity analysis of WT1-wild-type and WT1-mutant Wilms tumors. Genes Chromosomes Cancer 43:172-180.
24. Sakatani T, Kaneda A, Iacobuzio-Donahue CA, Carter MG, de Boom Witzel S, Okano H, Ko MS, Ohlsson R, Longo DL, Feinberg AP. 2005. Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice. Science 307:1976-1978.
25. Satoh Y, Nakagawachi T, Nakadate H, Kaneko Y, Masaki Z, Mukai T, Soejima H. 2003. Significant reduction of WT1 gene expression, possibly due to epigenetic alteration in Wilms' tumor. J Biochem 133:303-308.
26. Schroeder WT, Chao LY, Dao DD, Strong LC, Pathak S, Riccardi V, Lewis WH, Saunders GF. 1987. Nonrandom loss of maternal chromosome 11 alleles in Wilms tumors. Am J Hum Genet 40:413-420.
27. Tadokoro K, Oki N, Sakai A, Fujii H, Ohshima A, Nagafuchi S, Inoue T, Yamada M. PCR detection of 9 polymorphisms in the WT1 gene. 1993. Hum Mol Genet 2:2205-2206.
28. Watanabe N, Kobayashi H, Hirama T, Kikuta A, Koizumi S, Tsuru T, Kaneko Y. 2002. Cryptic t(12;15)(p13;q26) producing the ETV6-NTRK3 fusion gene and no loss of IGF2 imprinting in congenital mesoblastic nephroma with trisomy 11: fluorescence in situ hybridization and IGF2 allelic expression analysis. Cancer Genet Cytogenet 136:10-16.
29. Yeh A, Wei M, Golub SB, Yamashiro DJ, Murty VV, Tycko B. 2002. Chromosome arm 16q in Wilms tumors: unbalanced chromosomal translocations, loss of heterozygosity, and assessment of the CTCF gene. Genes Chromosomes Cancer 35:156-163.
30. Yuan E, Li CM, Yamashiro DJ, Kandel J, Thacker H, Murty W, Tycko B. 2005. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors. Mol Cancer Res 3:493-502.